Newsletter Subject

Wake Me Up When September Ends

From

outsiderclub.com

Email Address

newsletter@outsiderclub.com

Sent On

Mon, Sep 13, 2021 01:12 PM

Email Preheader Text

Plus, my top plays for the September slump... Plus, my top plays for the September slump... Written

Plus, my top plays for the September slump... Plus, my top plays for the September slump... [Outsider Club logo] Wake Me Up When September Ends [Alexander Boulden Photo] By [Alexander Boulden]( Written Sep 13, 2021 The September slump is here, and no one is feeling it more than Elizabeth Holmes. In case she fell off your radar, Holmes is the disgraced former CEO of Theranos, the now-dissolved startup that promised fast and accurate results for more than 200 diagnostic tests using a single drop of blood. Remember, folks, if it sounds too good to be true, it usually is. Theranos grew to a $9 billion valuation and by 2015, media tycoon Rupert Murdoch, former Secretary of Education Betsy DeVos, and the Walton family, founders of Walmart, invested more than $700 million. The story was good... too good. It seems like Holmes contrived her life story just to create the typical Silicon Valley company story, dropping out of Stanford at age 19 and building a product to disrupt the healthcare industry. Using the media to prop up her image — you surely remember the iconic black turtleneck and her fake deep voice — she was able to garner more investments. In doing so, she became the youngest self-made female billionaire in the world. But after a whistleblower sounded the alarm that Holmes was exaggerating the efficacy of test results and future earnings projections and patients complained when they received outrageous test results from Theranos machines at Walgreens, the government came knocking... Holmes sits in federal court today, indicted for 10 counts of wire fraud and two counts of conspiracy to commit wire fraud, including lying to investors, employees, doctors, and patients. She faces up to 20 years in prison. Holmes is unsurprisingly laying the blame on someone else, former president of Theranos and ex-boyfriend Ramesh Balwani, saying he psychologically, sexually, and emotionally abused her. But affectionate text messages between the two revealed in court last week paint a different picture. We can see her sad puppy dog eyes in this courtroom sketch, courtesy of Reuters... [holmes] [How to Turn $500 Into $20,500]( HINT: It has to do with a tiny piece of dirt recently discovered in rural Canada. What if I told you that you could turn $500 into $20,500 not once, not twice, but FIVE times over the course of the next few months? If that sounds like something you might like, then [click here to see the details of this rapidly unfolding opportunity.]( Of course, thanks to the U.S. justice system, she’s innocent until proven guilty and the jury gets to decide whether or not her exaggerations were intentional. But the fact that she’s blaming her illegal actions on someone else sounds like an admission of guilt and intent. Case closed. One big takeaway from this case is to always be mindful of so-called story stocks. Burton Malkiel warns in “A Random Walk Down Wall Street” that investing in story stocks is a psychological behavior following the “castles-in-the-air” theory of investing... The successful investor tries to beat the gun by estimating what investment situations are most susceptible to public castle-building and then buying before the crowd... Just as hope and greed can sometimes feed on themselves to produce speculative bubbles, so do pessimism and despair react to produce market panics. The greatest market panics are just as unfounded as the most pathological speculative explosions. Holmes knew investors would speculate on her “disruptive” technology because it supposedly gave patients a quick snapshot of their health. Using marketing, she duped us into believing the Theranos machine could do more than it could. It seemed like a good investment at the time, but as Jimi Hendrix said, “Castles in the sand fall in the sea... eventually.” The more important takeaway is that Americans are so desperate to get healthy that they’ll give their blood to a speculative biotech company led by an inexperienced college dropout. That’s because we Americans are notoriously unhealthy, but the U.S. ironically spends the most on healthcare when compared with other nations. The Atlantic recently reported less than 3% of Americans live a healthy lifestyle. And other studies have found the U.S. has the highest suicide rate and lowest life expectancy of developed countries. Perhaps that's why our daily deaths from COVID are comparatively high as well. [covid] It’s clear the healthcare industry is still rife for disruption, but not in the way you’d think... Have You Heard of “TriFuel-238”? A single ounce could power your home for a year. Under half an ounce could get you from LA to D.C. And now, according to figures from the U.S. Energy Information Administration... The breakthrough known as "TriFuel-238"... Could trigger a wealth event unseen since the dawn of the internet... As it takes the throne as the cheapest source of energy on the planet. This has nothing to do with renewables or fossil fuels — or virtually anything you’ve ever seen before. Yet this strange substance could now claim the lion’s share of a $1.9 trillion opportunity... And hand early investors a potential life-changing fortune. [Click here for the urgent details.]( Healthcare Growth Stocks Analysts are touting healthcare stocks as the next growth opportunity in the market. But you know how we feel about those analysts... They cover only half the story half the time. They’ll point to hospital real estate investment trusts (REITs), Big Pharma companies producing “vaccines,” or risky biotech companies that Martha Stewart wouldn’t even touch. By the way, if you like getting into legit biotechs early and watching them take off, you should [check out my colleague’s fast-paced biotech trading service](. Investment Director Keith Kohl developed a cash calendar that gives you [the opportunity to profit four to eight times every single month](. Keith works with a network of more than 250 doctors and scientists to bring you the inside scoop on some of the most disruptive biotechs out there. Just [click here]( for all the details... And aside from biotech, we should look outside the box to sectors of the economy that contribute to our health and well-being, including food, pets, transportation, and even financials. My Wish List The second week of October has been the historical bottom for the markets. In fact, the market crashes of 1929 and 1987 occurred in October and were preceded by slumps in September. So let’s take advantage of the dips we’re seeing now. Here’s what I’m watching: - Blue Apron (NYSE: APRN) looks undervalued as a play on healthy eating. Once more Americans realize processed food is literally killing them, they’ll turn to healthier alternatives. - CryoPort (NASDAQ: CYRX) is the leading transporter of the coronavirus vaccines and other medicines that need to be kept at frozen temperatures. With booster shots coming, this stock has more room to run. - ProShares Pet Care ETF (BATS: PAWZ) tracks the performance of the top pet care companies. Pets are great for mental health and keeping owners in shape. The industry is projected to grow to $350 billion by 2027. - Volta (NYSE: VLTA) makes and installs electric vehicle chargers, so this is a bet on U.S. infrastructure, EVs, and a healthy planet. Stay strong and carry on. To your wealth, Alexander Boulden Editor, Outsider Club --------------------------------------------------------------- “God Chips” Are Our Future Specifically, I’m talking about microchips. It’s not a sexy story but a necessary one that you need to know about. You see, with the advancement of artificial intelligence, 5G, and pretty much everything around us, there’s never been more of an overload on our computing system. It’s crucial that microchips keep up with all these cutting-edge technologies. Thankfully, microchip developments are already underway so technology like AI can work faster and more efficiently. There’s one company I’m looking at right now that’s leading the pack. The best part is this game-changing company is holding 14,000 patents for this technology, and it’s currently preparing for mass production. This can turn a mere $500 investment into a fortune. [Click here to get the details...]( Browse Our Archives [Biden Admin Backtracks on Inflation]( [One Million Missing Cars, One Million Times More Processing Power]( [Revolutionary Technology Creating New Jobs]( [This Stock Could Really Take Off]( [Two Spaces, Mundane and Profound]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2021, [Angel Publishing LLC]( & Outsider Club LLC, 3 E Read Street Baltimore, MD 21202. For Customer Service, please call (855) 496-0830. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of the editors of Outsider Club and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither the editors of Outsider Club, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. The editors of Outsider Club, entities that they control, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.

EDM Keywords (221)

yet year world well way watching want walgreens wake view usually use updated unfounded twice turn true told time throne think theranos technology talking takes take tailored susceptible sure subscription subject studies story stock statement stanford sounds solicitation slumps share shape september sent sell seeing see security securities sectors scientists sale room right reviewing responsibility renewables reliable received receive question purports purchase punishable publisher publication prospectus prop projected profound product preceded positions point play planet pessimism performance patients part pack overload opportunity opinions opinion one offer october nothing next newsletter never network neither need nations months mindful microchips meet medicines media means may markets market manage made looking lion letter let leading law la know kept investments investing internet intentional intention intended innocent information industry indirectly implied image illegal hope home holmes heard healthcare health half gun guilt guaranteed grow greed great good gives give get garner found figures fell feeling feel fact faces expression exaggerations exaggerating estimating ensure energy email efficiently efficacy editors economy distributed disruption disrupt discussed dips details desperate deemed dawn crucial crowd create covid cover course could contribute contents consulting conspiracy compared company colleague click clear claim check castles case carry buying buy building bring box blood blaming blame biotech bet believing believed became beat assumes aside anyone analysts americans always alarm advancement admission accurate according able 1929

Marketing emails from outsiderclub.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

03/12/2024

Sent On

02/12/2024

Sent On

26/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.